Home / Clinical Laboratory / Clinical Analyzer Calibrators and Reagents / Reagents / Reagent / Reagent Xpert® Molecular Diagnostic MRSA NxG 120 TestsGXMRSA-NXG-120
Picture of Reagent Xpert® Molecular Diagnostic MRSA NxG 120 TestsGXMRSA-NXG-120

Reagent Xpert® Molecular Diagnostic MRSA NxG 120 TestsGXMRSA-NXG-120

Reagent-Xpert®-Molecular-Diagnostic-MRSA-NxG-120-TestsGXMRSA-NXG-120

SKU #

#1056399

MPN #

GXMRSA-NXG-120

Brand

Cepheid

Stock

In Stock

Quantity

100

Features

REAGENT, IVD XPERT MRAS N/S LFD/S

$4,470.05 USD

Product Specifications Product Usage Additional Information
Print
Attribute Name Attribute Value
McKesson # 1056399
Manufacturer # GXMRSA-NXG-120
Brand Xpert®
Manufacturer Cepheid
Application Reagent
Container Type Cartridge
Number of Tests 120 Tests
Test Name MRSA NxG
Test Type Molecular Diagnostic
UNSPSC Code 41116011
Compare Selected Items Email

Similar Items

Underarm Crutches McKesson Aluminum Frame Tall Adult 350 lbs. Weight Capacity Push Button - Adjustment

One Size Fits Most White NonSterile Not Rated 8211

In Stock

PR/1 $9.76 USD

Underarm Crutches McKesson Aluminum Frame Tall Adult 350 lbs. Weight Capacity Push Button - Adjustment

One Size Fits Most White NonSterile Not Rated 8211

In Stock

PR/1 $9.76 USD

Underarm Crutches McKesson Aluminum Frame Tall Adult 350 lbs. Weight Capacity Push Button - Adjustment

One Size Fits Most White NonSterile Not Rated 8211

In Stock

PR/1 $9.76 USD

Underarm Crutches McKesson Aluminum Frame Tall Adult 350 lbs. Weight Capacity Push Button - Adjustment

One Size Fits Most White NonSterile Not Rated 8211

In Stock

PR/1 $9.76 USD

  • Control of MRSA in healthcare settings requires rapid and accurate tests to detect colonized patients
  • Approximately 171,200 healthcare-associated MRSA infections are acquired annually in the European Union (EU), resulting in 5,400 attributable deaths, more than 1 million excess days of hospitalization and € 380 million in excess in-hospital costs
  • Between 2 and 53 million people are estimated to carry MRSA worldwide
  • The average length of stay (LOS) for all MRSA patients in the EU is 11.5 days with an average attributable cost of € 7,478 per patient